John E. Byfield - Concepedia

Author

John E. Byfield

University of California, Los Angeles

Also Known As

J E Byfield, JOHN E. BYFIELD, John Byfield, John E Byfield, John E. Byfield

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles University of California San Diego UCLA Medical Center University of California San Diego Medical Center United States Department of Veterans Affairs

About

John E. Byfield is an author at University of California, Los Angeles specializing in medicine, molecular biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	25	1.1K
2	Natural Sciences	10	10	240
3	Health Sciences	4	4	123
4	Engineering	3	3	58
5	Public Health	1	1	15

John E. Byfield

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays John E. Byfield, Paula M. Calabro-Jones, Ivana Klisak, International Journal of Radiation OncologyBiologyPhysics OncologyHuman Tumor CellsRadiation TherapyMedicineAnti-cancer Agent	1982	390
A rapid radioassay technique for cellular suspensions John E. Byfield, Otto H. Scherbaum Analytical Biochemistry Cell CultureRapid Radioassay TechniqueCell ManipulationCell BiologyNuclear Medicine	1966	140
Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro. Paula M. Calabro-Jones, John E. Byfield, John F. Ward, PubMed Cell Cycle TimeMedicineTime-dose RelationshipsMetronomic TherapyPharmacology	1982	117
Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases Robert M. Barone, John E. Byfield, Paul B. Goldfarb, Cancer	1982	117
Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents John P. Murnane, John E. Byfield, John F. Ward, Nature Bifunctional Alkylating AgentsMammalian CellsMedicineToxicologyMethylated Xanthines	1980	76
Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents John E. Byfield, Paula M. Calabro-Jones Nature Medicinal ChemistryPolymer-drug ConjugateCarrier-independent TransportAnti-cancer AgentPharmacology	1981	68
Cellular effects of combined adriamycin and x‐irradiation in human tumor cells John E. Byfield, Maureen P. Lynch, Fimi Kulhanian, International Journal of Cancer Antibiotic AdjuvantRadiation EffectRadiation ExposureRadiation BiologyTumor Biology	1977	58
Induction of DNA Degradation In Vivo by Adriamycin 2 Young C. Lee, John E. Byfield JNCI Journal of the National Cancer Institute Dna DamageAntibiotic AdjuvantApoptosisMolecular BiologyCell Death	1976	57
Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiation John E. Byfield, Sallie S. Frankel, Thomas R. Sharp, International Journal of Radiation OncologyBiologyPhysics Medicinal ChemistryRadiation MedicineRadiation TherapyMedicineHyperfractionated Cyclical Radiation	1985	48
Molecular interactions between adriamycin and x‐ray damage in mammalian tumor cells John E. Byfield, Young C. Lee, Lorna Tu International Journal of Cancer	1977	45

Page 1